Login / Signup

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma.

Chan Yoon Y CheahDavid JoskeGavin CullMichael GilbertsonStephen S OpatConstantine S TamAndrew WirthJohn F Seymour
Published in: British journal of haematology (2016)
Keyphrases
  • diffuse large b cell lymphoma
  • stem cell transplantation
  • high dose
  • epstein barr virus
  • low dose
  • cell therapy
  • blood brain barrier
  • platelet rich plasma
  • stem cells
  • mesenchymal stem cells